Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | June 29, 2023 08:18am

Gainers

  • Eco Wave Power Global AB (NASDAQ:WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.
  • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares gained 33.1% to $3.98 in pre-market trading after the company secured $2.0 million National Institutes of Health SBIR grant to support clinical development of REM-001.
  • Fangdd Network Group Ltd. (NASDAQ:DUO) shares rose 21.7% to $0.9367 in pre-market trading after dropping 11% on Wednesday. FangDD Network Group recently received Nasdaq notice regarding minimum bid price requirements.
  • BlackBerry Limited (NYSE:BB) shares rose 18.5% to $5.94 in pre-market trading after the company reported better-than-expected fiscal first-quarter results.
  • Emerson Radio Corp. (NYSE:MSN) shares gained 18.5% to $0.64 in pre-market trading.
  • Akso Health Group (NASDAQ:AHG) shares climbed 18.2% to $0.39 in pre-market trading after gaining around 5% on Wednesday.
  • Better Choice Company Inc. (NYSE:BTTR) rose 16.7% to $0.2690 in pre-market trading after declining around 8% on Wednesday. Better Choice recently announced a $5 million investment from Alphia, establishing a direct manucafturing relationship.
  • AIM ImmunoTech Inc. (NYSE:AIM) gained 15.8% to $0.6830 in pre-market trading after gaining around 5% on Wednesday. AIM ImmunoTech recently announced publication of findings from a pre-clinical study evaluating Ampligen in the treatment of pancreatic cancer in the American Journal of Cancer Research.
  • ZIVO Bioscience, Inc. (NASDAQ:ZIVO) rose 14.5% to $2.69 in pre-market trading after declining over 3% on Wednesday.
  • Shapeways Holdings, Inc. (NYSE:SHPW) gained 11.9% to $3.30 in pre-market trading after the company announced securing two new Tier 1 supplier contracts.

Losers

  • CorMedix Inc. (NASDAQ:CRMD) fell 21.6% to $3.97 in pre-market trading after the company reported pricing of $40 million public offering of common stock and pre-funded warrants.
  • iMedia Brands, Inc. (NASDAQ:IMBI) fell 14.1% to $0.1656 in pre-market trading after jumping 20% on Wednesday.
  • Novan, Inc. (NASDAQ:NOVN) fell 13.4% to $0.3971 in pre-market after gaining over 12% on Wednesday.
  • Knightscope, Inc. (NASDAQ:KSCP) fell 11.4% to $0.6201 in pre-market trading after jumping 52% on Wednesday. The company's CEO made comments about 2023 projections on the Stock Day podcast.
  • Minerva Neurosciences, Inc. (NASDAQ:NERV) fell 10.1% to $9.16 in pre-market trading. Minerva Neurosciences shares jumped over 69% on Wednesday after the company announced a $20 million private placement priced at a premium to the market.
  • Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) shares dropped 10% to $5.16 in pre-market trading after the company reported a $75 million proposed public offering of common stock.
  • Surgalign Holdings, Inc. (NASDAQ:SRGA) shares dropped 10% to $0.27 in pre-market trading after gaining 11% on Wednesday. Surgalign Holdings’ subsidiary Holo Surgical was granted European Patent Number EP3751516 titled "Autonomous Multidimensional Segmentation Of Anatomical Structures On Three-Dimensional Medical Imaging."
  • Centogene N.V. (NASDAQ:CNTG) fell 8.9% to $1.44 in pre-market trading after jumping 34% on Wednesday. CENTOGENE and Lifera recently formed a Saudi Arabian joint venture.
  • Appreciate Holdings, Inc. (NASDAQ:SFR) fell 8.1% to $0.3739 in pre-market trading after gaining 7% on Wednesday.
  • Jaguar Health, Inc. (NASDAQ:JAGX) shares fell 7% to $0.4820 in pre-market trading. Napo Pharmaceuticals, a Jaguar Health Company, submitted investigational new drug application to the FDA for microvillus inclusion disease.

 

Now Read This: Investor Optimism Improves After Nasdaq Settles Higher

Posted In: AHG AIM BB BDTX BTTR CNTG CRMD DUO IMBI JAGX KSCP KTRA MSN NERV NOVN SFR SHPW SRGA WAVE ZIVO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist